Arkema Financial Statements From 2010 to 2025
| ARKAF Stock | USD 80.65 0.00 0.00% |
Check Arkema SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arkema SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Arkema financial statements analysis is a perfect complement when working with Arkema SA Valuation or Volatility modules.
Arkema |
Arkema SA Company Current Valuation Analysis
Arkema SA's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Arkema SA Current Valuation | 8.73 B |
Most of Arkema SA's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arkema SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Arkema SA has a Current Valuation of 8.73 B. This is 23.51% lower than that of the Basic Materials sector and 71.67% lower than that of the Specialty Chemicals industry. The current valuation for all United States stocks is 47.5% higher than that of the company.
Arkema SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Arkema SA's current stock value. Our valuation model uses many indicators to compare Arkema SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Arkema SA competition to find correlations between indicators driving Arkema SA's intrinsic value. More Info.Arkema SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.22 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Arkema SA is roughly 4.59 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Arkema SA's earnings, one of the primary drivers of an investment's value.About Arkema SA Financial Statements
Arkema SA stakeholders use historical fundamental indicators, such as Arkema SA's revenue or net income, to determine how well the company is positioned to perform in the future. Although Arkema SA investors may analyze each financial statement separately, they are all interrelated. For example, changes in Arkema SA's assets and liabilities are reflected in the revenues and expenses on Arkema SA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Arkema SA. Please read more on our technical analysis and fundamental analysis pages.
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France. Arkema operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 19441 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Arkema Pink Sheet
Arkema SA financial ratios help investors to determine whether Arkema Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arkema with respect to the benefits of owning Arkema SA security.